Lumexa Imaging
Raleigh, North Carolina, United States · Biotechnology, Health Care, Manufacturing
Lumexa Imaging is one of the nation’s largest providers of outpatient medical imaging, with a mission to expand access to advanced, high-quality, and affordable diagnostic care. We operate more than 180 centers across 13 states, including more than 85 centers in joint ventures with leading health systems. With over 5,000 team members and a clinical network of more than 1,000 subspecialized radiolo
Key facts
- Headquarters
- Raleigh, North Carolina, United States
- Employees
- 5,000
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (LMRI)
- Website
- www.lumexaimaging.com
- Company page
Recent activity at Lumexa Imaging
- : Lumexa Imaging Enters Illinois Through New Partnership with Advocate Health
- : Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
- : SEC 8-K (7.01):
- : SEC 8-K (7.01):
- : SEC 8-K (1.01): On June 30, 2026, Lumexa Imaging, Inc. and Lumexa Imaging Outpatient, Inc. entered into an amendment to their existing Credit Agreement. This amended agreement provides a secured term loan facility of approximately $823 million and a revolving line of credit of $250 million. The term loan will bear interest either at SOFR plus 2.50% or the Prime Rate plus 1.50%, maturing in December 2032, while the revolving credit facility will have similar interest terms and is set to mature in December 2030. The amendment includes restrictive covenants that limit the Company’s subsidiaries in incurring additional debt and paying dividends, with specified financial covenants contingent on the revolving credit exposure. This strategic financial arrangement aims to strengthen the Company's capital structure while maintaining compliance with prescribed financial metrics.
- : SEC 8-K (7.01):
- : SEC 8-K (7.01): On April 8, 2026, Lumexa Imaging Holdings, Inc. provided a Regulation FD disclosure during a meeting and site visit where it reiterated its previously disclosed full year 2026 guidance. This event is significant as it indicates the Company’s confidence in meeting their financial projections amidst market conditions. The guidance outlined during this meeting is crucial for investors and stakeholders assessing the company's future performance and strategic direction.
- : SEC 8-K (7.01):
- : SEC 8-K (7.01):
- : SEC 8-K (5.02): On January 12, 2026, Ms. Julie Szeker, who served as the Chief Legal Officer and Corporate Secretary of Lumexa Imaging Holdings, Inc., submitted her resignation effective March 13, 2026. The resignation was not due to any disagreements regarding the Company's operations or practices. As part of the transition, Ms. Szeker entered into a Transition Agreement which includes a transition payment of $450,000 and up to 12 months of subsidized healthcare coverage, contingent on her compliance with certain terms. Furthermore, Ms. Szykler is set to receive an annual bonus of $250,000 for her 2025 performance, to be paid alongside other employees. This transition process highlights the Company's efforts to manage leadership changes strategically.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Kyle Lynch, Chief Growth Officer
- Russell Stewart, Chief Medical Officer
Verified email and direct lines for Lumexa Imaging’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Lumexa Imaging files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Lumexa Imaging in the news
- Lumexa Imaging Achieves Record De Novo Expansion in 2025 - PR Newswire (Jan 08, 2026)
- US RADIOLOGY SPECIALISTS REBRANDS AS LUMEXA IMAGING, USHERING IN A NEW ERA OF GROWTH AND TRANSFORMATION - Yahoo Finance (Jul 08, 2025)
- Lumexa Imaging Holdings (Nasdaq:LMRI) - Stock Analysis - Simply Wall St (Dec 11, 2025)
- Lumexa Imaging Holdings, Inc. (LMRI) stock price, news, quote and history - Yahoo Finance Australia (Aug 14, 2025)
- Lumexa Imaging Announces Pricing of Initial Public Offering - PR Newswire (Dec 10, 2025)
- Lumexa Imaging Holdings (NasdaqGS:LMRI) Stock Price - Simply Wall St (Dec 12, 2025)
- Lumexa Imaging Announces Launch of Initial Public Offering - PR Newswire (Dec 02, 2025)
Companies similar to Lumexa Imaging
- Masimo Corporation · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Corza Biosurgery · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- PHC株式会社 バイオメディカ事業部 · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Avanos Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Cordica · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About Lumexa Imaging: questions and answers
What does Lumexa Imaging do?
Lumexa Imaging is one of the nation’s largest providers of outpatient medical imaging, with a mission to expand access to advanced, high-quality, and affordable diagnostic care. We operate more than 180 centers across 13 states, including more than 85 centers in joint ventures with leading health systems. With over 5,000 team members and a clinical network of more than 1,000 subspecialized radiolo
Where is Lumexa Imaging headquartered?
Lumexa Imaging is headquartered in Raleigh, North Carolina, United States.
How many employees does Lumexa Imaging have?
Lumexa Imaging has about 5,000 employees.
What is the latest news on Lumexa Imaging?
On Nov 14, 2026, Lumexa Imaging Enters Illinois Through New Partnership with Advocate Health
Is Lumexa Imaging a public company?
Yes. Lumexa Imaging is publicly traded under the ticker LMRI.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy